Hemorrhagic cystitis in a patient receiving gemtuzumab ozogamicin for relapsed acute promyelocytic leukemia after cord blood transplantation

Ann Hematol. 2008 Oct;87(10):851-2. doi: 10.1007/s00277-008-0482-z. Epub 2008 Apr 3.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aminoglycosides* / adverse effects
  • Aminoglycosides* / therapeutic use
  • Antibodies, Monoclonal* / adverse effects
  • Antibodies, Monoclonal* / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents* / adverse effects
  • Antineoplastic Agents* / therapeutic use
  • Cord Blood Stem Cell Transplantation*
  • Cystitis / chemically induced*
  • Cystitis / pathology
  • Gemtuzumab
  • Hemorrhage / chemically induced*
  • Humans
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Male
  • Middle Aged
  • Recurrence

Substances

  • Aminoglycosides
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Gemtuzumab